These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1475232)

  • 1. Pharmacokinetic disposition of multiple-dose transdermal nicotine in healthy adult smokers.
    Kochak GM; Sun JX; Choi RL; Piraino AJ
    Pharm Res; 1992 Nov; 9(11):1451-5. PubMed ID: 1475232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking.
    Benowitz NL; Zevin S; Jacob P
    Br J Clin Pharmacol; 1997 Mar; 43(3):259-67. PubMed ID: 9088580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of multiple daily transdermal doses of nicotine in healthy smokers.
    Ross HD; Chan KK; Piraino AJ; John VA
    Pharm Res; 1991 Mar; 8(3):385-8. PubMed ID: 2052530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) and half-hourly cigarette smoking.
    Gupta SK; Hwang SS; Causey D; Rolf CN; Gorsline J
    J Clin Pharmacol; 1995 Oct; 35(10):985-9. PubMed ID: 8568016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and absorption kinetics of nicotine following application of a transdermal system.
    Gupta SK; Benowitz NL; Jacob P; Rolf CN; Gorsline J
    Br J Clin Pharmacol; 1993 Sep; 36(3):221-7. PubMed ID: 9114908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state pharmacokinetics and dose relationship of nicotine delivered from Nicoderm (Nicotine Transdermal System).
    Gorsline J; Gupta SK; Dye D; Rolf CN
    J Clin Pharmacol; 1993 Feb; 33(2):161-8. PubMed ID: 8440766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of smoking on the pharmacokinetics and pharmacodynamics of a nicotine patch.
    Yun HY; Seo JW; Choi JE; Baek IH; Kang W; Kwon KI
    Biopharm Drug Dispos; 2008 Dec; 29(9):521-8. PubMed ID: 19054833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal nicotine substitution: pharmacokinetics of nicotine and cotinine.
    Keller-Stanislawski B; Caspary S; Merz PG; Bonn R; Wolff M; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):417-21. PubMed ID: 8225689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System).
    Gupta SK; Okerholm RA; Coen P; Prather RD; Gorsline J
    J Clin Pharmacol; 1993 Feb; 33(2):169-74. PubMed ID: 8440767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-related cardiovascular and endocrine effects of transdermal nicotine.
    Zevin S; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 1998 Jul; 64(1):87-95. PubMed ID: 9695723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the pharmacokinetics of two nicotine transdermal systems: nicoderm and habitrol.
    Gupta SK; Okerholm RA; Eller M; Wei G; Rolf CN; Gorsline J
    J Clin Pharmacol; 1995 May; 35(5):493-8. PubMed ID: 7657849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment.
    Gourlay SG; Benowitz NL; Forbes A; McNeil JJ
    Eur J Clin Pharmacol; 1997; 51(5):407-14. PubMed ID: 9049583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of nicotine after application of a 30 cm2 nicotine patch under steady-state conditions.
    Caspary S; Keller-Stanislawski B; Huber T; Merz PG
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):92-5. PubMed ID: 2071260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine-mecamylamine interactions.
    Zevin S; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2000 Jul; 68(1):58-66. PubMed ID: 10945316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of nicotine and cotinine after application of two different nicotine patches under steady state conditions.
    Keller-Stanislawski B; Caspary S
    Arzneimittelforschung; 1992 Sep; 42(9):1160-2. PubMed ID: 1445487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable isotope method for studying transdermal drug absorption: the nicotine patch.
    Benowitz NL; Chan K; Denaro CP; Jacob P
    Clin Pharmacol Ther; 1991 Sep; 50(3):286-93. PubMed ID: 1914363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of nicotine, cotinine, and 3'-hydroxycotinine in cigarette smokers.
    Scherer G; Jarczyk L; Heller WD; Biber A; Neurath GB; Adlkofer F
    Klin Wochenschr; 1988; 66 Suppl 11():5-11. PubMed ID: 3184779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous nicotine retards transdermal absorption of nicotine: evidence of blood flow--limited percutaneous absorption.
    Benowitz NL; Jacob P; Olsson P; Johansson CJ
    Clin Pharmacol Ther; 1992 Sep; 52(3):223-30. PubMed ID: 1526077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic model of transdermal nicotine delivered from a matrix-type patch.
    Linakis MW; Rower JE; Roberts JK; Miller EI; Wilkins DG; Sherwin CMT
    Br J Clin Pharmacol; 2017 Dec; 83(12):2709-2717. PubMed ID: 28771779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine.
    Hukkanen J; Gourlay SG; Kenkare S; Benowitz NL
    Clin Pharmacol Ther; 2005 Mar; 77(3):159-69. PubMed ID: 15735610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.